Literature DB >> 26068894

A 3D human neural cell culture system for modeling Alzheimer's disease.

Young Hye Kim1, Se Hoon Choi2, Carla D'Avanzo2, Matthias Hebisch3, Christopher Sliwinski2, Enjana Bylykbashi2, Kevin J Washicosky2, Justin B Klee2, Oliver Brüstle4, Rudolph E Tanzi2, Doo Yeon Kim2.   

Abstract

Stem cell technologies have facilitated the development of human cellular disease models that can be used to study pathogenesis and test therapeutic candidates. These models hold promise for complex neurological diseases such as Alzheimer's disease (AD), because existing animal models have been unable to fully recapitulate all aspects of pathology. We recently reported the characterization of a novel 3D culture system that exhibits key events in AD pathogenesis, including extracellular aggregation of amyloid-β (Aβ) and accumulation of hyperphosphorylated tau. Here we provide instructions for the generation and analysis of 3D human neural cell cultures, including the production of genetically modified human neural progenitor cells (hNPCs) with familial AD mutations, the differentiation of the hNPCs in a 3D matrix and the analysis of AD pathogenesis. The 3D culture generation takes 1-2 d. The aggregation of Aβ is observed after 6 weeks of differentiation, followed by robust tau pathology after 10-14 weeks.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26068894      PMCID: PMC4499058          DOI: 10.1038/nprot.2015.065

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  43 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

3.  Protection of neurons derived from human neural progenitor cells by veratridine.

Authors:  Peter J Morgan; Stefanie Ortinau; Jana Frahm; Norman Krüger; Arndt Rolfs; Moritz J Frech
Journal:  Neuroreport       Date:  2009-08-26       Impact factor: 1.837

4.  Modeling familial Alzheimer's disease with induced pluripotent stem cells.

Authors:  Takuya Yagi; Daisuke Ito; Yohei Okada; Wado Akamatsu; Yoshihiro Nihei; Takahito Yoshizaki; Shinya Yamanaka; Hideyuki Okano; Norihiro Suzuki
Journal:  Hum Mol Genet       Date:  2011-09-07       Impact factor: 6.150

Review 5.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

Review 6.  Zinc-finger nucleases: the next generation emerges.

Authors:  Toni Cathomen; J Keith Joung
Journal:  Mol Ther       Date:  2008-06-10       Impact factor: 11.454

Review 7.  Alzheimer's disease in a dish: promises and challenges of human stem cell models.

Authors:  Jessica E Young; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-08-02       Impact factor: 6.150

8.  Taurine enhances the growth of neural precursors derived from fetal human brain and promotes neuronal specification.

Authors:  Reyna Hernández-Benítez; Sharada D Vangipuram; Gerardo Ramos-Mandujano; William D Lyman; Herminia Pasantes-Morales
Journal:  Dev Neurosci       Date:  2013-02-28       Impact factor: 2.984

9.  Glycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells.

Authors:  Alexandra Jaeger; Jana Baake; Dieter G Weiss; Ralf Kriehuber
Journal:  Int J Dev Neurosci       Date:  2012-10-18       Impact factor: 2.457

10.  Differentiation of human neural progenitor cells in functionalized hydrogel matrices.

Authors:  Andrea Liedmann; Stefanie Frech; Peter J Morgan; Arndt Rolfs; Moritz J Frech
Journal:  Biores Open Access       Date:  2012-01
View more
  83 in total

Review 1.  Alzheimer's in 3D culture: challenges and perspectives.

Authors:  Carla D'Avanzo; Jenna Aronson; Young Hye Kim; Se Hoon Choi; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Bioessays       Date:  2015-08-07       Impact factor: 4.345

2.  Reprogramming cells from Gulf War veterans into neurons to study Gulf War illness.

Authors:  Liang Qiang; Anand N Rao; Gustavo Mostoslavsky; Marianne F James; Nicole Comfort; Kimberly Sullivan; Peter W Baas
Journal:  Neurology       Date:  2017-05-16       Impact factor: 9.910

Review 3.  Stem cells technology: a powerful tool behind new brain treatments.

Authors:  Lucienne N Duru; Zhenzhen Quan; Talal Jamil Qazi; Hong Qing
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 4.  Sleep, Cognition and Dementia.

Authors:  Verna R Porter; William G Buxton; Alon Y Avidan
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

5.  Recapitulating amyloid β and tau pathology in human neural cell culture models: clinical implications.

Authors:  Se Hoon Choi; Young Hye Kim; Carla D'Avanzo; Jenna Aronson; Rudolph E Tanzi; Doo Yeon Kim
Journal:  US Neurol       Date:  2015

Review 6.  Three-Dimensional Models of the Human Brain Development and Diseases.

Authors:  Mehdi Jorfi; Carla D'Avanzo; Doo Yeon Kim; Daniel Irimia
Journal:  Adv Healthc Mater       Date:  2017-08-28       Impact factor: 9.933

Review 7.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

8.  Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.

Authors:  Lin Guo; Hong Joo Kim; Hejia Wang; John Monaghan; Fernande Freyermuth; Julie C Sung; Kevin O'Donovan; Charlotte M Fare; Zamia Diaz; Nikita Singh; Zi Chao Zhang; Maura Coughlin; Elizabeth A Sweeny; Morgan E DeSantis; Meredith E Jackrel; Christopher B Rodell; Jason A Burdick; Oliver D King; Aaron D Gitler; Clotilde Lagier-Tourenne; Udai Bhan Pandey; Yuh Min Chook; J Paul Taylor; James Shorter
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

Review 9.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

Review 10.  Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.

Authors:  Bradley Watmuff; Shaunna S Berkovitch; Joanne H Huang; Jonathan Iaconelli; Steven Toffel; Rakesh Karmacharya
Journal:  Mol Cell Neurosci       Date:  2016-01-14       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.